Will U.S. Doctors Prescribe Biosimilars?

Post By Charu Gupta

March 22, 2016

A new InCrowd MicroSyndicated Survey Report looks at what 150 physicians across multiple specialty areas commonly requiring prescription of biologics think about the coming market in biosimilars.

Our survey, administered using our real-time microsurvey technology platform, probes the intersections between market evolution and patient needs. See our infographic below for a summary of some of the key findings, and please contact us at to get a complimentary copy of the full report that includes doctor perspectives by specialty area.



Keep up with the latest market research news, trends and research from InCrowd